At Eurofins Discovery, the same scientists who helped build one of the industry’s largest portfolios of drug discovery assays are available to modify and customize those assays for the specifics of your drug discovery project. Choosing a custom-tailored solution can provide you with more incisive data, give your pipeline a competitive advantage, and save weeks or even months in your discovery timeline.
If you require completely new, highly custom, or specific assays for small molecules or biotherapeutics, we can assemble a cross-disciplinary scientific and project management team that brings over 40 years of experience to your specific needs in a range of key areas:
- For small molecule discovery, we can tailor or develop assays ranging from biochemical, enzymatic, radiolabel or MS (mass spectrometry) binding modes to functional phenotypic assays suitable for HTS, H2L (hit to lead), LO (lead optimization) screening and asset characterization for IND (investigational new drug application) filing.
- Our bespoke capabilities include strategies for assessment of target engagement, modulation, and degradation, as well as assessment of target-agnostic cellular functional outcomes.
- In biotherapeutics, our new assay development is backed by an experienced and dedicated team armed with leading-edge technologies to address your specific challenges.
Beyond assays, we provide custom protein engineering; cell line development; and cell banking for biomolecule testing, for bulk production of biomolecules, and for custom storage testing. At Eurofins Discovery, our single focus is moving your research forward, step by step, to the finish line.
